IMMUNE-MEDIATED NEPHRITIS

This adverse event was reported 18 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED NEPHRITIS:

# Drug Count
0 PEMBROLIZUMAB 8
1 NIVOLUMAB 7
2 CARBOPLATIN 5
3 IPILIMUMAB 5
4 PACLITAXEL 4
5 AMLODIPINE 3
6 CALCIUM CARBONATE 3
7 PREGABALIN 3
8 ALLOPURINOL 2
9 AMIFOSTINE 2
See all common drugs associated with IMMUNE-MEDIATED NEPHRITIS

IMMUNE-MEDIATED NEPHRITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LEVAMLODIPINE MALEATE 1 0.2000
1 AMIFOSTINE 2 0.0027
2 NALDEMEDINE 1 0.0015
3 PEMBROLIZUMAB 8 0.0004
4 AXITINIB 2 0.0002
5 IPILIMUMAB 5 0.0002
6 RUCAPARIB 1 0.0002
7 DAPSONE 1 0.0002
8 NIVOLUMAB 7 0.0002
9 CALCIUM GLUCONATE 1 0.0002
See all drugs enriched for association with IMMUNE-MEDIATED NEPHRITIS

These drug classes are most commonly taken by patients reporting IMMUNE-MEDIATED NEPHRITIS:

# Drug class Count
See all common drug classes associated with IMMUNE-MEDIATED NEPHRITIS

IMMUNE-MEDIATED NEPHRITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
See all drug classes enriched for association with IMMUNE-MEDIATED NEPHRITIS